These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 17761202)
1. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers]. Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of EGFR, p53 and E-cadherin in mucoepidermoid cancer of the salivary glands: a retrospective case series. Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A J Med Liban; 2007; 55(2):83-8. PubMed ID: 17685120 [TBL] [Abstract][Full Text] [Related]
3. [Mucoepidermoid carcinomas of salivary glands: prognostic significance of immunohistochemistry. A study of 49 cases]. Santini L; Coulibaly B; Gaudart J; Turner F; Michel J; Giovanni A; Dessi P; Fakhry N Rev Laryngol Otol Rhinol (Bord); 2012; 133(4-5):183-7. PubMed ID: 24006824 [TBL] [Abstract][Full Text] [Related]
4. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
5. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer. Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509 [TBL] [Abstract][Full Text] [Related]
6. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O Oncology; 2003; 64(4):389-98. PubMed ID: 12759537 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Yin HF; Okada N; Takagi M Pathol Int; 2000 Aug; 50(8):603-9. PubMed ID: 10972857 [TBL] [Abstract][Full Text] [Related]
8. Mucoepidermoid carcinoma of salivary glands in children and adolescents: assessment of proliferation markers. Hicks J; Flaitz C Oral Oncol; 2000 Sep; 36(5):454-60. PubMed ID: 10964053 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma. Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279 [TBL] [Abstract][Full Text] [Related]
11. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67. Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095 [TBL] [Abstract][Full Text] [Related]
12. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of P(53) and bcl-2 in benign and malignant salivary glands tumors. Al-Rawi NH; Omer H; Al Kawas S J Oral Pathol Med; 2010 Jan; 39(1):48-55. PubMed ID: 19761475 [TBL] [Abstract][Full Text] [Related]
15. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study. Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839 [TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands. Cardoso WP; Denardin OV; Rapoport A; Araújo VC; Carvalho MB Sao Paulo Med J; 2000 May; 118(3):69-74. PubMed ID: 10810331 [TBL] [Abstract][Full Text] [Related]
17. HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands. Nguyen LH; Black MJ; Hier M; Chauvin P; Rochon L J Otolaryngol; 2003 Oct; 32(5):328-31. PubMed ID: 14974865 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma. Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122 [TBL] [Abstract][Full Text] [Related]
19. Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature. Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D Oral Dis; 2006 Jul; 12(4):364-70. PubMed ID: 16792720 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population. Liu S; Ow A; Ruan M; Yang W; Zhang C; Wang L; Zhang C Int J Oral Maxillofac Surg; 2014 Jun; 43(6):667-73. PubMed ID: 24568836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]